Early research (Phase 1)Study completedNCT02106507
What this trial is testing
ARN 509 Plus Everolimus in Men With Progressive Metastatic Castration-Resistant Prostate Cancer After Treatment With Abiraterone Acetate
Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 9